To locate a project or a qualified biomarker go to CDER & CBER’s DDT Qualification Project Search database

Web content is updated for consistency with 21st Century Cures Act!

Get started with your submission

Resources for Biomarker Requestors

Mission

The mission of the CDER Biomarker Qualification Program (BQP) is to work with external stakeholders to develop biomarkers as drug development tools. Qualified biomarkers have the potential to advance public health by encouraging efficiencies and innovation in drug development. 

About FDA’s Biomarker Qualification Program

Transcript

Goals

  • Support outreach to stakeholders for the identification and development of new biomarkers
  • Provide a framework for the review of biomarkers for use in regulatory decision-making
  • Qualify biomarkers for specific contexts of use that address specified drug development needs

Additional Information

Contact us at: [email protected]

  • Content current as of:

    05/16/2025

  • Regulated Product(s)

    Topic(s)

    Law(s) & Regulation(s)

Source

Clinical :: Oncology :: Nuclear :: Geriatric :: Regulatory :: Technology :: Consulting

"My passion is helping businesses, small and large, perform at their best." - Felicia Udoji-Eddings, Pharm.D.

Dr. Felicia Udoji-Eddings is the Founder and CEO of The Health Pals Company, a vertically integrated Healthcare System. As an experienced Clinical Pharmacy Leader, Pharmacy Consultant, Healthcare Executive, and Licensed Pharmacy Practitioner with deep backgrounds in Information Technology (IT), Scientific Research, and Business Management. Dr. Udoji-Eddings has a strong track record of exceptional performance in different business environments. A skilled Business Strategist, Dr. Udoji-Eddings has tackled complex problems and helped several organizations refocus their strategy in tough economic times. As a highly motivated and proactive individual, Felicia enjoys working with teams, in various capacities, to facilitate positive outcomes.